Stay updated on Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial page.

Latest updates to the Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe footer now identifies the website as running revision v3.8.0 instead of v3.7.2.SummaryDifference0.0%

- Check21 days agoChange DetectedA site-wide NIH notice announces updates and explains that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.2%

- Check28 days agoChange DetectedThe website footer now identifies the site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check35 days agoChange DetectedThe footer's ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check56 days agoChange DetectedA new revision label, v3.7.0, was added to the history and the previous label, v3.6.6, was removed. This reflects an update to the platform's revision metadata and does not alter study data or page content.SummaryDifference0.0%

- Check77 days agoChange DetectedA new Revision: v3.6.6 entry was added and the previous Revision: v3.6.5 entry was removed in the study's record history. This reflects a backend update to the history-tracking system, not a change to the study details.SummaryDifference0.0%

Stay in the know with updates to Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial page.